News Focus
News Focus
Followers 68
Posts 2917
Boards Moderated 0
Alias Born 04/22/2022

Re: HyGro post# 792198

Sunday, 10/12/2025 9:35:47 PM

Sunday, October 12, 2025 9:35:47 PM

Post# of 823770
Gro,

It sounds like you can hear the Thundering Herd advancing into our midst!



Northwest Biotherapeutics (Pittsburgh, UCLA, Roswell Park)

ImmunoRestoration (Moffitt)

Mill Creek Life Sciences (Mayo Clinic)

Diakonos Oncology

NWBO appears to be emerging as the leader, with academic/industry relationships, a broad IP portfolio, manufacturing capacity, & multiple platforms…

But the key point is that it’s not a zero-sum game. Success in any one clinical trial, institution, or company validates the field of cell-based technology, reinforces proof of concept, & advances the science—opening doors to broader adoption, broader market demand, regulatory confidence, & investor interest.

Beyond those examples mentioned above, more companies are emerging— & others soon will. Each will make a contribution to the field & may create opportunities for collaboration, partnerships, or acquisitions.

Kalinski Heads to Pitt



Recent Conference

Pennies in Action

Moffitt
Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News